JIUN-KAE JACK LEE's research topics

JIUN-KAE JACK LEE

Concepts (842)

Back to Profile

Concepts are derived automatically from a person's publications.

Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.

Name	Number of Publications	Most Recent Publication	Publications by All Authors	Concept Score	Why?
Mouth Neoplasms	38	2013	734	2.040	Why?
Isotretinoin	33	2012	160	2.000	Why?
Research Design	18	2020	1569	1.960	Why?
Data Interpretation, Statistical	10	2012	483	1.920	Why?
Lung Neoplasms	100	2020	12019	1.910	Why?
Carcinoma, Non-Small-Cell Lung	68	2015	5566	1.730	Why?
Anticarcinogenic Agents	21	2011	368	1.650	Why?
Bayes Theorem	11	2020	1058	1.580	Why?
Carcinoma, Squamous Cell	71	2015	5585	1.550	Why?
Randomized Controlled Trials as Topic	19	2015	2646	1.530	Why?
Drug Interactions	7	2015	574	1.400	Why?
Precancerous Conditions	35	2013	1033	1.340	Why?
Smoking	41	2014	2548	1.250	Why?
Clinical Trials as Topic	12	2017	3842	1.080	Why?
Head and Neck Neoplasms	42	2015	4139	1.040	Why?
Clinical Trials, Phase II as Topic	7	2015	686	1.010	Why?
Bronchi	14	2012	324	1.010	Why?
Dose-Response Relationship, Drug	25	2015	5062	0.870	Why?
Biomarkers, Tumor	45	2015	10694	0.850	Why?
Antineoplastic Agents	48	2015	14613	0.790	Why?
Models, Statistical	10	2013	1185	0.760	Why?
Antineoplastic Combined Chemotherapy Protocols	43	2015	16640	0.730	Why?
Molecular Targeted Therapy	14	2015	2390	0.700	Why?
Respiratory Mucosa	8	2012	212	0.690	Why?
Biometry	5	2007	250	0.650	Why?
ErbB Receptors	17	2015	2376	0.630	Why?
Neoplasms	27	2017	15900	0.620	Why?
Leukoplakia, Oral	12	2010	71	0.620	Why?
Humans	295	2020	270026	0.570	Why?
Middle Aged	183	2015	90031	0.540	Why?
Receptors, Retinoic Acid	15	2005	369	0.510	Why?
Neoplasms, Second Primary	15	2012	1387	0.510	Why?
Precision Medicine	8	2015	1207	0.510	Why?
Male	198	2015	127915	0.500	Why?
Tretinoin	10	2007	618	0.500	Why?
Sample Size	6	2013	213	0.490	Why?
Aged	154	2015	73128	0.490	Why?
Biomarkers	11	2013	5046	0.490	Why?
Female	199	2015	148487	0.470	Why?
Fenretinide	8	2009	100	0.450	Why?
Glutamates	3	2013	132	0.450	Why?
Trimetrexate	2	2010	12	0.440	Why?
Gene Expression Profiling	17	2014	5137	0.440	Why?
Laryngeal Neoplasms	6	2010	529	0.430	Why?
Gene Dosage	8	2014	823	0.430	Why?
Carcinoma, Small Cell	7	2007	427	0.420	Why?
Disease-Free Survival	38	2015	10258	0.420	Why?
Adenocarcinoma	32	2015	7883	0.420	Why?
Survival Analysis	27	2014	9288	0.420	Why?
Statistics as Topic	4	2010	452	0.410	Why?
Neoplasm Staging	53	2015	13994	0.410	Why?
Phosphatidylinositol 3-Kinases	9	2014	1707	0.400	Why?
Smoking Cessation	8	2008	771	0.400	Why?
Insulin-Like Growth Factor Binding Protein 3	3	2011	156	0.400	Why?
Clinical Trials, Phase I as Topic	8	2014	622	0.390	Why?
alpha-Tocopherol	4	2009	80	0.390	Why?
Treatment Outcome	57	2014	33692	0.390	Why?
Neoplasm Recurrence, Local	24	2015	10382	0.380	Why?
Polymorphism, Single Nucleotide	10	2012	4646	0.370	Why?
Immunohistochemistry	30	2014	7632	0.370	Why?
Adult	132	2015	81692	0.370	Why?
Quinazolines	7	2015	956	0.370	Why?
Cyclin D1	6	2013	589	0.360	Why?
Cisplatin	21	2014	2496	0.360	Why?
Chi-Square Distribution	4	2012	1309	0.360	Why?
Folic Acid	2	2010	369	0.350	Why?
Mutation	26	2015	15900	0.350	Why?
Prognosis	52	2015	22451	0.340	Why?
Proportional Hazards Models	24	2013	5099	0.340	Why?
Models, Theoretical	3	2012	798	0.340	Why?
Tumor Suppressor Protein p53	14	2013	3653	0.330	Why?
Anti-Inflammatory Agents, Non-Steroidal	4	2008	533	0.330	Why?
Gene Expression Regulation, Neoplastic	35	2014	9035	0.320	Why?
DNA, Neoplasm	13	2012	1957	0.320	Why?
Aged, 80 and over	66	2015	30923	0.320	Why?
Combinatorial Chemistry Techniques	1	2007	34	0.300	Why?
Pleural Neoplasms	4	2014	485	0.300	Why?
Drug Resistance, Neoplasm	10	2015	5403	0.300	Why?
Survival Rate	31	2015	12508	0.290	Why?
Drug Design	1	2010	371	0.290	Why?
Drug Screening Assays, Antitumor	5	2015	562	0.290	Why?
Drug Approval	5	2015	174	0.290	Why?
Mesothelioma	4	2014	558	0.290	Why?
Computer Simulation	7	2013	1570	0.280	Why?
Soft Tissue Neoplasms	1	2014	914	0.280	Why?
Tumor Suppressor Proteins	7	2012	1899	0.280	Why?
Tongue Neoplasms	2	2005	253	0.280	Why?
Vascular Endothelial Growth Factor Receptor-2	3	2014	265	0.270	Why?
Multivariate Analysis	21	2013	4318	0.270	Why?
Prostatic Neoplasms	13	2008	5855	0.270	Why?
Genes, ras	5	2012	679	0.270	Why?
Cell Line, Tumor	26	2015	14824	0.260	Why?
Vinblastine	7	2010	462	0.260	Why?
Protein Kinase Inhibitors	11	2015	4958	0.250	Why?
Models, Biological	4	2008	3187	0.250	Why?
Mouth Mucosa	7	2012	224	0.240	Why?
Risk Factors	30	2014	17824	0.240	Why?
Decision Support Techniques	2	2006	601	0.240	Why?
Taxoids	10	2013	1016	0.240	Why?
Cranial Irradiation	1	2006	322	0.230	Why?
Receptor, IGF Type 1	5	2014	351	0.230	Why?
Kaplan-Meier Estimate	16	2014	6253	0.230	Why?
Pyrimidines	5	2013	3662	0.230	Why?
Carcinogenicity Tests	1	2003	69	0.220	Why?
Receptor, Platelet-Derived Growth Factor beta	3	2014	151	0.220	Why?
Skin Neoplasms	14	2014	4887	0.220	Why?
Colonic Neoplasms	8	2005	1427	0.220	Why?
Combined Modality Therapy	16	2013	9039	0.220	Why?
Insulin-Like Growth Factor I	3	2014	629	0.220	Why?
Sarcoma	1	2014	1836	0.220	Why?
Cell Transformation, Neoplastic	10	2010	2448	0.210	Why?
Polycomb Repressive Complex 2	2	2014	161	0.210	Why?
Polymerase Chain Reaction	16	2012	3468	0.210	Why?
Genetic Predisposition to Disease	14	2012	5773	0.210	Why?
Disease Progression	18	2015	6840	0.210	Why?
Neoplasm Proteins	7	2014	3343	0.210	Why?
Platinum	4	2015	142	0.210	Why?
Algorithms	8	2015	3897	0.200	Why?
Patient Selection	7	2017	2026	0.200	Why?
Ki-67 Antigen	4	2013	675	0.200	Why?
Gene Transfer Techniques	7	2012	804	0.200	Why?
Biological Therapy	1	2002	57	0.200	Why?
DNA Repair	5	2015	1910	0.200	Why?
Controlled Clinical Trials as Topic	1	2001	32	0.200	Why?
Drug Synergism	4	2010	1359	0.190	Why?
Piperidines	4	2013	1086	0.190	Why?
Proto-Oncogene Proteins c-akt	8	2014	2072	0.190	Why?
Genes, p53	6	2003	1140	0.190	Why?
Placebos	7	2011	443	0.190	Why?
Drug Therapy, Combination	1	2007	2326	0.190	Why?
Loss of Heterozygosity	5	2012	622	0.190	Why?
Proto-Oncogene Proteins	8	2013	2616	0.190	Why?
ras Proteins	7	2013	804	0.180	Why?
Epithelial Cells	4	2011	1867	0.180	Why?
Carboplatin	6	2015	879	0.180	Why?
Lung	6	2013	3288	0.180	Why?
Quality of Life	11	2012	4772	0.180	Why?
Salvage Therapy	4	2015	2122	0.180	Why?
Vascular Endothelial Growth Factor A	5	2014	1577	0.180	Why?
Cell Division	10	2004	2651	0.170	Why?
Interferon-alpha	12	2009	957	0.170	Why?
Time Factors	26	2015	12953	0.170	Why?
Tumor Burden	4	2014	2031	0.170	Why?
Genes, p16	4	2008	132	0.170	Why?
PTEN Phosphohydrolase	3	2014	1011	0.170	Why?
Angiogenesis Inducing Agents	2	2010	104	0.170	Why?
Confidence Intervals	3	2007	748	0.170	Why?
Deoxycytidine	3	2012	1389	0.170	Why?
Cardiovascular Diseases	2	2010	2209	0.170	Why?
Polymorphism, Genetic	4	2009	1557	0.170	Why?
Chemotherapy, Adjuvant	10	2014	3993	0.160	Why?
TOR Serine-Threonine Kinases	7	2014	1563	0.160	Why?
Cyclooxygenase 2 Inhibitors	2	2011	198	0.160	Why?
Fluorescence	4	2012	198	0.160	Why?
National Cancer Institute (U.S.)	2	2017	218	0.160	Why?
Follow-Up Studies	17	2015	15172	0.160	Why?
Cell Survival	4	2009	3055	0.160	Why?
Genetic Therapy	6	2012	1713	0.160	Why?
DNA-Binding Proteins	7	2013	5000	0.160	Why?
Probability	6	2008	883	0.160	Why?
RNA, Messenger	18	2009	6367	0.160	Why?
beta Carotene	6	2009	73	0.150	Why?
Proto-Oncogene Proteins c-met	2	2013	427	0.150	Why?
Finasteride	3	2008	29	0.150	Why?
Quality-Adjusted Life Years	3	2011	236	0.150	Why?
Melanoma	11	2014	5594	0.150	Why?
Brain Neoplasms	4	2015	4955	0.150	Why?
Cluster Analysis	6	2014	1068	0.150	Why?
Chromosomes, Human, Pair 9	6	2002	298	0.150	Why?
Double-Blind Method	9	2011	2586	0.150	Why?
Tissue Preservation	1	1997	27	0.140	Why?
Epithelial-Mesenchymal Transition	2	2013	1002	0.140	Why?
Drug Antagonism	2	2007	33	0.140	Why?
Microwaves	1	1997	33	0.140	Why?
Tumor Cells, Cultured	11	2011	5756	0.140	Why?
Chemoprevention	7	2013	251	0.140	Why?
Receptors, G-Protein-Coupled	2	2012	485	0.140	Why?
Pyrazoles	3	2011	1539	0.140	Why?
Sulfonamides	4	2011	1933	0.140	Why?
Case-Control Studies	14	2010	6204	0.140	Why?
Biopsy	14	2012	3384	0.140	Why?
Class I Phosphatidylinositol 3-Kinases	6	2014	529	0.130	Why?
Genotype	10	2011	4249	0.130	Why?
Software	2	2015	1356	0.130	Why?
Metaplasia	6	2003	343	0.130	Why?
Insulin-Like Growth Factor II	2	2014	112	0.130	Why?
Reproducibility of Results	9	2015	6182	0.130	Why?
Genes, Neoplasm	2	2014	314	0.130	Why?
Tissue Array Analysis	6	2014	757	0.130	Why?
Promoter Regions, Genetic	6	2008	3210	0.130	Why?
Neoplasms, Squamous Cell	2	2014	84	0.130	Why?
Microtubules	2	2014	326	0.130	Why?
Proteomics	3	2014	1426	0.130	Why?
Sensitivity and Specificity	10	2012	5153	0.130	Why?
Decision Making	1	2013	1249	0.130	Why?
Receptor, EphA5	1	2015	8	0.130	Why?
Breast Neoplasms	11	2014	16182	0.120	Why?
Neoadjuvant Therapy	6	2013	5225	0.120	Why?
Colorectal Neoplasms	6	2014	3699	0.120	Why?
Niacinamide	2	2013	428	0.120	Why?
In Situ Hybridization	10	2007	1039	0.120	Why?
Apoptosis	11	2013	7740	0.120	Why?
Alcohol Drinking	5	2013	600	0.120	Why?
Transcription Factors	6	2013	5432	0.120	Why?
Epithelium	9	2001	773	0.120	Why?
United States	11	2017	15776	0.120	Why?
Genetic Variation	5	2010	2165	0.120	Why?
Drug Administration Schedule	11	2015	3524	0.120	Why?
Carbonic Anhydrases	1	2014	50	0.120	Why?
Mouth	2	2009	124	0.120	Why?
M Phase Cell Cycle Checkpoints	1	2014	30	0.120	Why?
Predictive Value of Tests	10	2009	4944	0.120	Why?
Membrane Glycoproteins	3	2009	1094	0.120	Why?
Regression Analysis	7	2009	1568	0.120	Why?
Cytokines	3	2010	2810	0.120	Why?
Cell Cycle	5	2015	2136	0.120	Why?
Bias	2	2008	214	0.120	Why?
Oligonucleotide Array Sequence Analysis	8	2014	2472	0.120	Why?
Fiber Optic Technology	2	2012	146	0.110	Why?
Lymph Nodes	6	2005	3070	0.110	Why?
Cell Cycle Proteins	5	2014	2115	0.110	Why?
Interleukin-2	5	2002	889	0.110	Why?
DNA Damage	5	2015	1981	0.110	Why?
Recurrence	8	2013	4873	0.110	Why?
Proto-Oncogene Protein c-ets-2	1	2013	21	0.110	Why?
Prospective Studies	20	2015	13378	0.110	Why?
Camptothecin	3	2003	540	0.110	Why?
Lymphatic Metastasis	9	2014	4956	0.110	Why?
Stochastic Processes	1	2013	49	0.110	Why?
Up-Regulation	10	2014	2417	0.110	Why?
Proto-Oncogene Proteins c-bcl-2	3	1996	1542	0.110	Why?
Phenylurea Compounds	2	2013	599	0.110	Why?
SEER Program	2	2015	1047	0.110	Why?
United States Food and Drug Administration	4	2015	323	0.110	Why?
Vitamin A	3	2009	91	0.110	Why?
Genetic Heterogeneity	1	2014	326	0.110	Why?
Carcinogens	3	2009	391	0.110	Why?
Diagnostic Imaging	2	2012	1174	0.110	Why?
Likelihood Functions	2	2012	241	0.110	Why?
Cadherins	3	2013	655	0.110	Why?
Receptors, Interleukin-8B	1	2012	58	0.100	Why?
Microsatellite Repeats	4	2004	627	0.100	Why?
Reverse Transcriptase Polymerase Chain Reaction	8	2014	3599	0.100	Why?
Carcinoma in Situ	2	2011	488	0.100	Why?
Chromosomes, Human, Pair 3	5	2002	324	0.100	Why?
Positron-Emission Tomography	3	2012	2196	0.100	Why?
G2 Phase Cell Cycle Checkpoints	1	2012	78	0.100	Why?
Paclitaxel	7	2015	2101	0.100	Why?
Cell Proliferation	8	2014	7230	0.100	Why?
Tomography, X-Ray Computed	5	2013	7779	0.100	Why?
Odds Ratio	4	2012	2296	0.100	Why?
Glutathione Transferase	3	2011	367	0.100	Why?
Drug Combinations	2	2014	635	0.100	Why?
Adenosine	1	2014	296	0.100	Why?
Adenoviridae	4	2003	1496	0.100	Why?
Folate Receptor 1	1	2012	61	0.100	Why?
In Situ Hybridization, Fluorescence	7	2013	2308	0.100	Why?
Aneuploidy	2	2004	377	0.100	Why?
Cyclooxygenase 2	3	2009	494	0.100	Why?
Leukocytes	1	2013	415	0.100	Why?
Proto-Oncogene Proteins p21(ras)	6	2013	1400	0.090	Why?
Receptor, Insulin	1	2011	110	0.090	Why?
DNA Methylation	7	2012	2760	0.090	Why?
ROC Curve	5	2013	1248	0.090	Why?
Erlotinib Hydrochloride	4	2015	398	0.090	Why?
Retinoid X Receptor alpha	1	2011	39	0.090	Why?
Cause of Death	2	2010	778	0.090	Why?
Cost-Benefit Analysis	4	2011	965	0.090	Why?
Lymphocytes	5	2002	1272	0.090	Why?
High-Throughput Nucleotide Sequencing	3	2014	2353	0.090	Why?
Down-Regulation	4	2011	2089	0.090	Why?
Arachidonate 15-Lipoxygenase	2	2002	92	0.090	Why?
Carcinoma, Ductal, Breast	2	2013	1229	0.090	Why?
Radiography, Thoracic	1	2013	477	0.090	Why?
Proto-Oncogene Proteins B-raf	3	2013	1327	0.090	Why?
Neoplasm Invasiveness	8	2013	4043	0.090	Why?
Calcium-Calmodulin-Dependent Protein Kinases	2	2002	222	0.090	Why?
Microscopy, Fluorescence, Multiphoton	1	2010	61	0.090	Why?
Cocarcinogenesis	1	2010	56	0.090	Why?
Acne Vulgaris	1	2010	42	0.090	Why?
Image-Guided Biopsy	1	2013	336	0.090	Why?
Prostatic Intraepithelial Neoplasia	2	2001	81	0.090	Why?
Signal Transduction	10	2014	12083	0.090	Why?
Tissue Extracts	1	2010	50	0.090	Why?
RGS Proteins	1	2010	60	0.090	Why?
Clinical Trials, Phase III as Topic	3	2013	499	0.090	Why?
Pattern Recognition, Automated	1	2010	120	0.090	Why?
Telomere	1	2013	548	0.090	Why?
Cell Movement	4	2013	2457	0.090	Why?
Interleukin-1 Receptor-Associated Kinases	1	2009	38	0.090	Why?
Electronics, Medical	1	1989	15	0.090	Why?
Risk	6	2013	1937	0.090	Why?
Analysis of Variance	5	2010	2316	0.090	Why?
Tea	1	2009	46	0.090	Why?
Animals	19	2015	61707	0.090	Why?
Maximum Tolerated Dose	5	2013	1320	0.080	Why?
Mice	15	2015	35461	0.080	Why?
Protein Biosynthesis	1	2013	1028	0.080	Why?
ATP-Binding Cassette Transporters	1	2011	317	0.080	Why?
Administration, Oral	6	2015	1603	0.080	Why?
Receptors, Growth Factor	1	2010	157	0.080	Why?
Mutagens	3	2002	191	0.080	Why?
Somatomedins	1	2009	74	0.080	Why?
American Cancer Society	1	2009	35	0.080	Why?
Antibodies, Monoclonal, Humanized	5	2013	3398	0.080	Why?
Surgery, Computer-Assisted	1	2011	261	0.080	Why?
Thermography	1	1989	57	0.080	Why?
Pharyngeal Neoplasms	1	2010	142	0.080	Why?
Statistics, Nonparametric	2	2010	982	0.080	Why?
MicroRNAs	3	2014	2883	0.080	Why?
Phytotherapy	1	2009	103	0.080	Why?
Cephalexin	1	1988	8	0.080	Why?
Dental Care	1	1988	14	0.080	Why?
Isoenzymes	2	2002	650	0.080	Why?
Respiratory Tract Neoplasms	2	1999	40	0.080	Why?
Joint Prosthesis	1	1988	15	0.080	Why?
Metronidazole	1	1989	163	0.080	Why?
Estrogen Receptor alpha	2	2013	692	0.080	Why?
Rats, Inbred F344	4	2003	239	0.080	Why?
Immunoenzyme Techniques	4	2012	1183	0.080	Why?
Angiogenesis Inhibitors	3	2013	1265	0.080	Why?
Telomerase	2	2003	546	0.080	Why?
Laryngeal Diseases	1	2009	54	0.080	Why?
Systems Biology	1	2009	114	0.080	Why?
Estrogen Receptor beta	1	2009	149	0.080	Why?
Premedication	1	1988	133	0.080	Why?
Endothelial Growth Factors	2	2000	231	0.080	Why?
DNA Mutational Analysis	5	2014	2357	0.080	Why?
Cohort Studies	7	2012	9464	0.080	Why?
Receptor Protein-Tyrosine Kinases	1	2012	678	0.080	Why?
Digestive System Neoplasms	2	1999	78	0.080	Why?
Spectrum Analysis	1	2009	143	0.080	Why?
Acid Anhydride Hydrolases	2	2008	84	0.080	Why?
Lymphokines	2	2000	312	0.080	Why?
Chromosomes, Human, Pair 17	3	2002	668	0.080	Why?
Retrospective Studies	20	2015	39738	0.080	Why?
Mitomycin	1	2009	213	0.080	Why?
DNA Helicases	1	2011	450	0.080	Why?
AMP-Activated Protein Kinases	1	2011	396	0.080	Why?
Receptor, Fibroblast Growth Factor, Type 2	1	2008	95	0.080	Why?
Vitamins	1	2008	150	0.080	Why?
Fibroblast Growth Factor 2	1	2008	241	0.080	Why?
Bleomycin	4	2002	482	0.080	Why?
Penicillins	1	1988	166	0.070	Why?
Hypoxia-Inducible Factor 1, alpha Subunit	1	2010	393	0.070	Why?
Neoplasm Metastasis	8	2014	5309	0.070	Why?
Prostate	2	2006	1088	0.070	Why?
Dacarbazine	5	2002	502	0.070	Why?
Plant Extracts	1	2009	225	0.070	Why?
S Phase	3	1997	288	0.070	Why?
Face	1	1989	251	0.070	Why?
Eflornithine	2	1998	60	0.070	Why?
Receptors, Progesterone	2	2013	1603	0.070	Why?
Oncogenes	1	2011	700	0.070	Why?
Logistic Models	5	2012	3438	0.070	Why?
Antigens, Neoplasm	1	2014	1580	0.070	Why?
Receptor, Fibroblast Growth Factor, Type 1	1	2008	185	0.070	Why?
Quality Assurance, Health Care	1	2012	596	0.070	Why?
Nanoparticles	1	2012	585	0.070	Why?
Endpoint Determination	1	2008	179	0.070	Why?
Proto-Oncogene Proteins pp60(c-src)	1	2007	99	0.070	Why?
Registries	1	2015	2205	0.070	Why?
Image Enhancement	1	2010	553	0.070	Why?
Models, Econometric	1	2006	14	0.070	Why?
Image Interpretation, Computer-Assisted	1	2010	583	0.070	Why?
Neutropenia	2	2009	1006	0.070	Why?
Chromosome Aberrations	4	2002	2031	0.070	Why?
Enzyme Inhibitors	3	2006	1942	0.070	Why?
Appendiceal Neoplasms	1	2009	251	0.070	Why?
Immunologic Factors	3	2003	671	0.070	Why?
Selenomethionine	1	2006	40	0.070	Why?
Transcription Factor RelA	1	2006	184	0.070	Why?
Chemoradiotherapy	1	2015	2027	0.070	Why?
Selenium	1	2006	51	0.070	Why?
Life Expectancy	1	2006	129	0.070	Why?
Mice, Nude	4	2015	4329	0.070	Why?
Norway	1	2005	42	0.070	Why?
Random Allocation	3	2003	740	0.060	Why?
Drug Delivery Systems	1	2010	661	0.060	Why?
Antibiotics, Antineoplastic	1	2009	742	0.060	Why?
Evidence-Based Medicine	1	2010	1032	0.060	Why?
Uterine Cervical Dysplasia	2	1998	209	0.060	Why?
Tobacco Use Disorder	1	2008	300	0.060	Why?
Celecoxib	3	2011	198	0.060	Why?
Mice, Inbred BALB C	2	2015	2452	0.060	Why?
Ploidies	2	1995	250	0.060	Why?
Bacterial Infections	1	1988	508	0.060	Why?
Vitamin E	4	2000	132	0.060	Why?
DNA Sequence, Unstable	1	2004	7	0.060	Why?
Pneumonectomy	1	2010	862	0.060	Why?
Decision Trees	1	2005	181	0.060	Why?
Prostate-Specific Antigen	4	2002	1029	0.060	Why?
Genital Neoplasms, Female	1	2012	788	0.060	Why?
Quality Improvement	1	2012	912	0.060	Why?
Hyperthermia, Induced	1	2009	511	0.060	Why?
Rats	5	2015	6499	0.060	Why?
Ovarian Neoplasms	3	2014	4785	0.060	Why?
Mortality	1	1986	347	0.060	Why?
Incidence	6	2009	5806	0.060	Why?
Acetaminophen	1	2005	125	0.060	Why?
Cyclin-Dependent Kinase Inhibitor p16	2	2004	506	0.060	Why?
Gene Amplification	3	2013	766	0.060	Why?
Young Adult	9	2015	22134	0.060	Why?
Forecasting	2	2005	699	0.060	Why?
Analgesics, Non-Narcotic	1	2005	131	0.060	Why?
Antibodies, Monoclonal	6	2015	4462	0.060	Why?
Triple Negative Breast Neoplasms	1	2014	1388	0.060	Why?
Breast	2	2003	1366	0.060	Why?
DNA (Cytosine-5-)-Methyltransferases	1	2006	314	0.060	Why?
Health Surveys	1	2005	399	0.060	Why?
2-Acetylaminofluorene	1	2003	14	0.060	Why?
Antimetabolites, Antineoplastic	2	2002	1347	0.060	Why?
Food Deprivation	1	2003	48	0.060	Why?
Genes, Tumor Suppressor	1	2007	1125	0.060	Why?
Pulmonary Disease, Chronic Obstructive	1	2012	1061	0.060	Why?
Nuclear Proteins	2	2014	3437	0.050	Why?
Cytarabine	1	1989	2013	0.050	Why?
Trans-Activators	1	2009	1620	0.050	Why?
Adolescent	12	2015	32646	0.050	Why?
Thiazoles	1	2007	723	0.050	Why?
Genetic Vectors	6	2012	1856	0.050	Why?
Antimutagenic Agents	2	1993	5	0.050	Why?
Erythroplasia	1	2002	7	0.050	Why?
Colon	2	1996	653	0.050	Why?
7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide	2	2002	96	0.050	Why?
Remission Induction	5	2012	3648	0.050	Why?
Subtraction Technique	1	2002	143	0.050	Why?
Neopterin	2	2000	14	0.050	Why?
Neovascularization, Pathologic	2	2000	1581	0.050	Why?
Enhancer of Zeste Homolog 2 Protein	2	2014	263	0.050	Why?
RNA, Neoplasm	4	2011	806	0.050	Why?
Feasibility Studies	3	2015	2358	0.050	Why?
Neoplasms, Glandular and Epithelial	1	2006	517	0.050	Why?
Bevacizumab	3	2013	958	0.050	Why?
HIV Infections	1	2014	2153	0.050	Why?
Bronchoscopy	4	2012	481	0.050	Why?
Dermatologic Agents	1	2001	44	0.050	Why?
Severity of Illness Index	2	2015	4360	0.050	Why?
Inhibitory Concentration 50	2	2015	285	0.050	Why?
Intercellular Signaling Peptides and Proteins	1	2004	657	0.050	Why?
DNA, Complementary	1	2002	936	0.050	Why?
Texas	6	2014	6430	0.050	Why?
Phenotype	5	2012	6485	0.050	Why?
Uterine Cervical Neoplasms	3	2012	1900	0.050	Why?
Linoleic Acids	1	2000	32	0.050	Why?
Proliferating Cell Nuclear Antigen	1	2001	197	0.040	Why?
Fluorouracil	3	2013	1989	0.040	Why?
Leukoplakia	2	1997	6	0.040	Why?
Prostaglandin-Endoperoxide Synthases	1	2001	230	0.040	Why?
Genes, erbB-1	2	2013	104	0.040	Why?
Extracellular Signal-Regulated MAP Kinases	2	2012	470	0.040	Why?
Antineoplastic Agents, Phytogenic	2	2002	894	0.040	Why?
Xenograft Model Antitumor Assays	3	2014	3911	0.040	Why?
Gene Knockdown Techniques	2	2013	1077	0.040	Why?
Neoplasms, Experimental	1	2003	784	0.040	Why?
Salivary Gland Neoplasms	1	2004	497	0.040	Why?
Hemagglutinins	1	1999	36	0.040	Why?
Tissue Distribution	3	2009	927	0.040	Why?
Microcirculation	1	2000	187	0.040	Why?
Gene Expression Regulation	2	2008	4118	0.040	Why?
Cyclooxygenase Inhibitors	1	2000	177	0.040	Why?
Chromosomes	2	1998	324	0.040	Why?
Neoplastic Stem Cells	1	2007	1456	0.040	Why?
Infusions, Intravenous	4	2005	1435	0.040	Why?
Pyridines	1	2006	1310	0.040	Why?
Hyperplasia	3	2008	557	0.040	Why?
Recombinant Proteins	5	2007	3023	0.040	Why?
Age Factors	4	2011	5449	0.040	Why?
Lymphoscintigraphy	1	1999	35	0.040	Why?
Matrix Metalloproteinase 2	1	2000	257	0.040	Why?
Histones	2	1997	1512	0.040	Why?
Exome	2	2014	1248	0.040	Why?
Gene Expression Regulation, Enzymologic	3	2012	693	0.040	Why?
Cell Hypoxia	2	2010	353	0.040	Why?
Chromosome Mapping	2	2000	1655	0.040	Why?
Diterpenes	2	2009	115	0.040	Why?
Urinary Bladder Neoplasms	1	2011	2431	0.040	Why?
Antigens, Differentiation	1	1999	245	0.040	Why?
Heterogeneous-Nuclear Ribonucleoprotein Group A-B	1	1998	15	0.040	Why?
Carcinoma	3	1999	2607	0.040	Why?
Matrix Metalloproteinase 9	1	2000	349	0.040	Why?
Glioblastoma	1	2009	1773	0.040	Why?
Technetium Tc 99m Sulfur Colloid	1	1998	113	0.040	Why?
Carotenoids	3	1995	103	0.040	Why?
Imatinib Mesylate	2	2013	1690	0.040	Why?
Proteins	1	2006	2042	0.040	Why?
Immunoblotting	2	2012	892	0.040	Why?
Blotting, Western	3	2014	3585	0.040	Why?
Pseudogenes	1	1998	91	0.040	Why?
Multiple Myeloma	1	2009	2281	0.040	Why?
Cetuximab	2	2009	474	0.040	Why?
Chromosomes, Human, Pair 13	1	1998	149	0.040	Why?
Monophenol Monooxygenase	1	1997	60	0.040	Why?
In Situ Nick-End Labeling	3	2006	436	0.040	Why?
Bone Neoplasms	1	2010	2663	0.040	Why?
Neoplasm Grading	2	2012	1821	0.040	Why?
Benzamides	2	2013	1878	0.040	Why?
Conjunctivitis	1	1997	29	0.040	Why?
Protein Array Analysis	2	2011	501	0.030	Why?
Polyamines	1	1997	80	0.030	Why?
Jejunoileal Bypass	1	1996	6	0.030	Why?
Markov Chains	2	2008	185	0.030	Why?
Papillomaviridae	2	2010	636	0.030	Why?
Calcium Carbonate	1	1996	29	0.030	Why?
Exons	2	2012	1381	0.030	Why?
Poly(ADP-ribose) Polymerases	1	1998	315	0.030	Why?
Vincristine	1	2000	1581	0.030	Why?
Lymph Node Excision	3	1999	2056	0.030	Why?
Etoposide	2	2012	905	0.030	Why?
Carcinoma, Bronchogenic	1	1995	35	0.030	Why?
Radiotherapy, Adjuvant	3	2010	2269	0.030	Why?
Bromodeoxyuridine	1	1996	129	0.030	Why?
Calcitonin	1	1996	182	0.030	Why?
Mutagenesis	1	1997	519	0.030	Why?
Hypertriglyceridemia	1	1997	115	0.030	Why?
Liver Neoplasms	1	2013	4814	0.030	Why?
Retroviridae	1	1996	373	0.030	Why?
Teratogens	2	2011	92	0.030	Why?
Membrane Proteins	3	2014	2926	0.030	Why?
Cervix Uteri	1	1997	247	0.030	Why?
Health Fairs	1	1995	1	0.030	Why?
Rats, Nude	1	2015	28	0.030	Why?
Carcinoma, Large Cell	1	1995	98	0.030	Why?
Leukocytes, Mononuclear	1	1998	712	0.030	Why?
Chemical and Drug Induced Liver Injury	1	1997	201	0.030	Why?
Pilot Projects	3	2008	2843	0.030	Why?
Multicenter Studies as Topic	2	2012	558	0.030	Why?
Intestinal Polyps	1	1995	72	0.030	Why?
Micronuclei, Chromosome-Defective	1	1994	32	0.030	Why?
Nonlinear Dynamics	1	2015	76	0.030	Why?
Biopsy, Needle	2	2013	1376	0.030	Why?
Microscopy, Fluorescence	1	1997	765	0.030	Why?
China	2	2012	634	0.030	Why?
Esophageal Neoplasms	2	2005	3234	0.030	Why?
Drug Eruptions	1	1997	271	0.030	Why?
Carbonic Anhydrase IX	1	2014	40	0.030	Why?
Carcinoembryonic Antigen	1	1994	230	0.030	Why?
Sex Factors	2	2011	2170	0.030	Why?
Nitric Oxide	1	1998	659	0.030	Why?
Tubulin Modulators	1	2014	65	0.030	Why?
Papillomavirus Infections	2	2014	999	0.030	Why?
Epothilones	1	2014	55	0.030	Why?
Ifosfamide	2	2009	357	0.030	Why?
Piperazines	2	2013	2145	0.030	Why?
Radiopharmaceuticals	2	2010	1341	0.030	Why?
Pemetrexed	1	2013	100	0.030	Why?
Phosphorylation	2	2012	4937	0.030	Why?
Receptors, Platelet-Derived Growth Factor	1	2013	108	0.030	Why?
Continuity of Patient Care	1	1995	206	0.030	Why?
Fluorodeoxyglucose F18	2	2010	1260	0.030	Why?
Mouth Diseases	1	2013	38	0.030	Why?
Area Under Curve	1	2015	729	0.030	Why?
Radioimmunoassay	2	2005	203	0.030	Why?
Lipocalins	1	2013	54	0.030	Why?
Interleukin-9	1	2013	37	0.030	Why?
Paraffin Embedding	1	2013	221	0.030	Why?
Guanine	1	2013	157	0.030	Why?
DNA Primers	3	2004	1494	0.030	Why?
Topotecan	2	2009	248	0.030	Why?
Telomere Shortening	1	2013	56	0.030	Why?
Acute-Phase Proteins	1	2013	85	0.030	Why?
Cross-Sectional Studies	2	2012	4470	0.030	Why?
Inflammation	3	2009	2491	0.030	Why?
Lipocalin-2	1	2013	77	0.030	Why?
Treatment Failure	3	2006	1426	0.030	Why?
Enzyme Activation	2	2007	1800	0.030	Why?
beta 2-Microglobulin	1	1993	189	0.030	Why?
Peritoneal Neoplasms	1	1999	855	0.030	Why?
Cyclophosphamide	1	2000	3242	0.030	Why?
Everolimus	1	2015	436	0.030	Why?
Gene Deletion	1	1998	1472	0.030	Why?
Chromosome Deletion	1	1997	1049	0.030	Why?
Medical Oncology	2	2013	1463	0.030	Why?
Chromatography, High Pressure Liquid	2	2005	589	0.030	Why?
Hepatocyte Growth Factor	1	2013	155	0.030	Why?
Diarrhea	1	1996	712	0.030	Why?
Gene Expression	3	2009	3630	0.030	Why?
Replication Protein C	1	2012	22	0.030	Why?
TNF-Related Apoptosis-Inducing Ligand	1	2013	210	0.030	Why?
Bridged-Ring Compounds	1	2013	190	0.030	Why?
Mice, Transgenic	2	2011	4209	0.030	Why?
Quaternary Ammonium Compounds	1	2012	66	0.030	Why?
Injections, Subcutaneous	2	2003	341	0.030	Why?
Alopecia	1	2012	123	0.030	Why?
Fatty Acids, Monounsaturated	1	2012	75	0.030	Why?
Mastectomy, Modified Radical	1	1992	75	0.030	Why?
Tetrahydronaphthalenes	1	2012	114	0.020	Why?
Risk Assessment	3	2012	6752	0.020	Why?
Technology, Radiologic	1	2012	78	0.020	Why?
Insulin Receptor Substrate Proteins	1	2012	144	0.020	Why?
Mucositis	1	2012	148	0.020	Why?
Early Termination of Clinical Trials	1	2011	84	0.020	Why?
Credentialing	1	2012	61	0.020	Why?
Tertiary Care Centers	1	2014	417	0.020	Why?
Proto-Oncogene Proteins c-sis	1	2011	76	0.020	Why?
Ribosomal Protein S6 Kinases, 90-kDa	1	2012	89	0.020	Why?
Cell Differentiation	1	2002	4103	0.020	Why?
Flow Cytometry	3	1997	3037	0.020	Why?
Radiotherapy, Intensity-Modulated	2	2015	2161	0.020	Why?
Death-Associated Protein Kinases	2	2002	22	0.020	Why?
Aspartic Acid	1	2012	135	0.020	Why?
Neoplastic Processes	1	2011	16	0.020	Why?
Radiation Tolerance	1	2015	637	0.020	Why?
Kisspeptins	1	2011	12	0.020	Why?
Valine	1	2012	180	0.020	Why?
Lentivirus	1	2012	164	0.020	Why?
Sulindac	2	2002	55	0.020	Why?
Pulmonary Surfactant-Associated Protein A	1	2011	15	0.020	Why?
Gene Silencing	2	2004	827	0.020	Why?
Pulmonary Surfactant-Associated Protein C	1	2011	11	0.020	Why?
Pulmonary Surfactant-Associated Protein B	1	2011	14	0.020	Why?
Chromosomes, Human	1	2012	288	0.020	Why?
Suppression, Genetic	1	2011	70	0.020	Why?
Radiotherapy	2	2012	1857	0.020	Why?
Thyroid Nuclear Factor 1	1	2011	51	0.020	Why?
Hematologic Diseases	1	2012	255	0.020	Why?
Catalytic Domain	2	2003	305	0.020	Why?
Receptor, Platelet-Derived Growth Factor alpha	1	2011	125	0.020	Why?
Ku Autoantigen	1	2011	82	0.020	Why?
Lung Injury	1	2012	145	0.020	Why?
Alcoholism	1	2014	329	0.020	Why?
Cysteine	1	2012	213	0.020	Why?
Fluorescent Antibody Technique	2	2007	1119	0.020	Why?
Polymorphism, Single-Stranded Conformational	2	2003	192	0.020	Why?
Microarray Analysis	1	2012	396	0.020	Why?
Nausea	1	2012	540	0.020	Why?
GTP Phosphohydrolases	1	2012	335	0.020	Why?
Immunoprecipitation	1	2012	589	0.020	Why?
Canada	1	2011	439	0.020	Why?
Real-Time Polymerase Chain Reaction	1	2014	1197	0.020	Why?
Dose-Response Relationship, Radiation	2	2002	751	0.020	Why?
Drug Resistance	2	2006	609	0.020	Why?
Adenoma	1	1995	725	0.020	Why?
Plasmids	1	2012	936	0.020	Why?
Cartilage	1	2010	110	0.020	Why?
Carcinosarcoma	1	2011	146	0.020	Why?
Transfection	2	2007	3115	0.020	Why?
Cell Nucleus	2	2009	1711	0.020	Why?
Health Services Needs and Demand	1	1992	246	0.020	Why?
Mice, Knockout	2	2011	5693	0.020	Why?
DNA Repair Enzymes	1	2011	235	0.020	Why?
Sampling Studies	1	1989	170	0.020	Why?
Glycine	1	2012	318	0.020	Why?
Color	1	1989	73	0.020	Why?
Sepharose	1	2009	35	0.020	Why?
Karyopherins	1	2010	134	0.020	Why?
Induction Chemotherapy	1	2012	670	0.020	Why?
Longitudinal Studies	2	2005	2056	0.020	Why?
Injections, Intraperitoneal	1	2009	209	0.020	Why?
Infusions, Parenteral	1	2009	194	0.020	Why?
Radiotherapy Dosage	2	2012	3999	0.020	Why?
Linear Models	1	2012	1095	0.020	Why?
Alphapapillomavirus	1	2011	172	0.020	Why?
Vascular Endothelial Growth Factors	2	2000	246	0.020	Why?
Ubiquitin-Conjugating Enzymes	1	2009	96	0.020	Why?
Molecular Sequence Data	3	2004	6674	0.020	Why?
Proteome	1	2012	571	0.020	Why?
Drug Evaluation, Preclinical	1	2010	498	0.020	Why?
Nose	1	1989	140	0.020	Why?
DNA Breaks, Double-Stranded	1	2011	327	0.020	Why?
Granulocyte Colony-Stimulating Factor	2	2003	770	0.020	Why?
Interleukin-1	1	2009	471	0.020	Why?
Survivors	1	1994	1022	0.020	Why?
Pain	1	1997	1697	0.020	Why?
Joint Diseases	1	1988	71	0.020	Why?
Apoptosis Regulatory Proteins	2	2002	622	0.020	Why?
Human papillomavirus 16	1	2010	255	0.020	Why?
Protein Kinases	1	2012	897	0.020	Why?
Tobacco Use Cessation	1	2008	30	0.020	Why?
Computational Biology	1	2014	1293	0.020	Why?
Chromosomal Proteins, Non-Histone	1	2010	376	0.020	Why?
Mutagenicity Tests	2	1998	70	0.020	Why?
Hydroxamic Acids	1	2010	454	0.020	Why?
DNA Copy Number Variations	1	2014	1552	0.020	Why?
Tumor Stem Cell Assay	1	2007	230	0.020	Why?
Laryngectomy	1	2009	243	0.020	Why?
Image Processing, Computer-Assisted	2	1997	1688	0.020	Why?
Adaptor Proteins, Signal Transducing	1	2014	1469	0.020	Why?
Cytoplasm	1	2009	699	0.020	Why?
Polymorphism, Restriction Fragment Length	1	2007	275	0.020	Why?
Patient Compliance	1	2011	676	0.020	Why?
Neck	1	1989	393	0.020	Why?
Leukemia	1	1996	1719	0.020	Why?
Blotting, Northern	1	2007	723	0.020	Why?
Transcriptional Activation	1	2011	1107	0.020	Why?
Palliative Care	3	2012	2173	0.020	Why?
Transcription, Genetic	3	2002	3336	0.020	Why?
Cell Culture Techniques	1	2009	573	0.020	Why?
Pneumonia	1	2012	795	0.020	Why?
Biological Products	1	2010	319	0.020	Why?
DNA Nucleotidylexotransferase	1	2006	56	0.020	Why?
Mastectomy, Segmental	1	1992	1049	0.020	Why?
Histone Deacetylase Inhibitors	1	2010	617	0.020	Why?
Electrophoresis, Polyacrylamide Gel	1	2006	596	0.020	Why?
Seminal Vesicles	1	2006	149	0.020	Why?
Intestinal Mucosa	3	1997	1081	0.020	Why?
Molecular Diagnostic Techniques	1	2008	334	0.020	Why?
Antioxidants	2	2000	520	0.020	Why?
Cell Line	2	1993	5334	0.020	Why?
Spectrometry, Fluorescence	1	2006	205	0.020	Why?
Academic Medical Centers	1	2009	681	0.020	Why?
Retinoids	1	2006	149	0.020	Why?
Embryonic Stem Cells	1	2007	277	0.020	Why?
Ultraviolet Rays	1	2007	588	0.020	Why?
RNA, Small Interfering	1	2011	2196	0.020	Why?
Repressor Proteins	1	2013	1716	0.020	Why?
Homozygote	1	2007	772	0.020	Why?
Transcriptome	1	2014	1954	0.020	Why?
Sulfites	1	2004	45	0.020	Why?
Aurora Kinases	1	2005	193	0.020	Why?
DNA Restriction Enzymes	1	2004	161	0.020	Why?
Health Services Research	1	2006	235	0.020	Why?
Cells, Cultured	2	2006	5658	0.010	Why?
Carcinoma, Basal Cell	1	2007	286	0.010	Why?
Parotid Neoplasms	1	2005	150	0.010	Why?
Hodgkin Disease	1	1993	1485	0.010	Why?
Cholecystitis	1	2004	58	0.010	Why?
Parotid Gland	1	2004	116	0.010	Why?
Transplantation, Autologous	1	2009	2045	0.010	Why?
Base Sequence	2	2004	5425	0.010	Why?
Cyclin-Dependent Kinase Inhibitor p27	1	2005	299	0.010	Why?
Cell Adhesion Molecules	1	2006	556	0.010	Why?
Aurora Kinase A	1	2005	210	0.010	Why?
Azacitidine	1	2010	1217	0.010	Why?
Genomics	1	2014	2834	0.010	Why?
Dasatinib	1	2007	881	0.010	Why?
Thrombocytopenia	2	2001	870	0.010	Why?
Receptor, ErbB-2	1	2013	2650	0.010	Why?
Monitoring, Physiologic	1	2006	520	0.010	Why?
Sepsis	1	1988	686	0.010	Why?
NF-kappa B	1	2009	1560	0.010	Why?
Chronic Disease	1	2008	1808	0.010	Why?
Surveys and Questionnaires	2	1992	5906	0.010	Why?
Protein Isoforms	1	2005	847	0.010	Why?
Triglycerides	1	2005	610	0.010	Why?
GATA6 Transcription Factor	1	2002	20	0.010	Why?
Endometrial Neoplasms	1	2012	1388	0.010	Why?
Gallbladder Neoplasms	1	2004	244	0.010	Why?
Microvilli	1	2002	86	0.010	Why?
Glutathione S-Transferase pi	1	2002	67	0.010	Why?
Social Adjustment	2	1992	114	0.010	Why?
Cholesterol	1	2005	658	0.010	Why?
Evaluation Studies as Topic	2	1992	447	0.010	Why?
Cotinine	1	2001	42	0.010	Why?
Cloning, Molecular	1	2004	1430	0.010	Why?
Government	1	2001	18	0.010	Why?
Agranulocytosis	1	2001	83	0.010	Why?
Interinstitutional Relations	1	2001	37	0.010	Why?
Health Care Costs	1	2006	698	0.010	Why?
Prostatectomy	1	2006	1003	0.010	Why?
Palpation	1	2000	51	0.010	Why?
Injections, Intravenous	1	2002	591	0.010	Why?
Caffeic Acids	1	2000	6	0.010	Why?
Drug Industry	1	2001	88	0.010	Why?
Infant, Newborn	1	1994	8668	0.010	Why?
Nitrobenzenes	1	2000	32	0.010	Why?
Early Detection of Cancer	1	2009	1338	0.010	Why?
Nitrites	1	2000	68	0.010	Why?
National Institutes of Health (U.S.)	1	2001	196	0.010	Why?
Mass Screening	1	2009	1545	0.010	Why?
Gas Chromatography-Mass Spectrometry	1	2000	95	0.010	Why?
Receptors, Interleukin-2	1	2000	194	0.010	Why?
Macrophage Activation	1	2000	150	0.010	Why?
Kinetics	1	2003	2186	0.010	Why?
Galectin 1	1	1999	20	0.010	Why?
Injections, Intralesional	1	2000	166	0.010	Why?
Disease Models, Animal	2	2007	7342	0.010	Why?
Chromosomes, Human, Pair 10	1	2000	142	0.010	Why?
Chromosomes, Human, Pair 21	1	2000	102	0.010	Why?
Sentinel Surveillance	1	1999	33	0.010	Why?
Adenoviruses, Human	1	2000	191	0.010	Why?
CpG Islands	1	2002	671	0.010	Why?
Melanoma, Amelanotic	1	1998	9	0.010	Why?
Pancreatic Neoplasms	1	1996	5250	0.010	Why?
Antibody Formation	1	2000	385	0.010	Why?
Methylation	1	2000	624	0.010	Why?
Fever	1	2002	520	0.010	Why?
Staining and Labeling	1	2000	434	0.010	Why?
Galectin 3	1	1999	131	0.010	Why?
Biogenic Polyamines	1	1998	3	0.010	Why?
Organ Specificity	1	2000	734	0.010	Why?
Ornithine Decarboxylase	1	1998	35	0.010	Why?
Rosaniline Dyes	1	1998	109	0.010	Why?
Interleukins	1	2000	341	0.010	Why?
Ornithine	1	1998	42	0.010	Why?
Immunity, Cellular	1	2000	438	0.010	Why?
False Negative Reactions	1	1998	284	0.010	Why?
Cytotoxicity, Immunologic	1	2000	683	0.010	Why?
Interleukin-10	1	2000	482	0.010	Why?
Centrifugation, Density Gradient	1	1997	158	0.010	Why?
Reference Values	1	1999	1130	0.010	Why?
Cheilitis	1	1997	4	0.010	Why?
Enzyme-Linked Immunosorbent Assay	1	2000	1512	0.010	Why?
Guidelines as Topic	1	1999	360	0.010	Why?
DNA Probes	1	1997	245	0.010	Why?
DNA, Viral	1	1999	753	0.010	Why?
Melphalan	1	1999	875	0.010	Why?
Mitotic Index	1	1996	162	0.010	Why?
Alkaline Phosphatase	1	1997	213	0.010	Why?
Starvation	1	1996	24	0.010	Why?
Leucovorin	1	1997	345	0.010	Why?
Alanine Transaminase	1	1997	237	0.010	Why?
Interleukin-6	1	2000	1042	0.010	Why?
Stomatitis	1	1997	193	0.010	Why?
Cell Count	1	1996	506	0.010	Why?
Mexican Americans	1	1998	331	0.010	Why?
Leukopenia	1	1996	152	0.010	Why?
Fatigue	1	2002	1278	0.010	Why?
Lymphocyte Activation	1	2000	1717	0.010	Why?
Tumor Necrosis Factor-alpha	1	2000	1570	0.010	Why?
Internet	1	1999	690	0.010	Why?
Arginine	1	1998	507	0.010	Why?
Peptide Fragments	1	2000	1305	0.010	Why?
Microscopy, Confocal	1	1996	658	0.010	Why?
Heterozygote	1	1997	1055	0.010	Why?
Macrophages	1	2000	1338	0.010	Why?
Physical Examination	1	1995	304	0.010	Why?
Ultrasonography	1	2000	1928	0.010	Why?
Amino Acid Sequence	1	2000	4561	0.010	Why?
Antibodies, Viral	1	2000	1296	0.010	Why?
Los Angeles	1	1992	34	0.010	Why?
Feces	1	1996	855	0.010	Why?
RNA	1	1997	1063	0.010	Why?
Ascorbic Acid	1	1993	131	0.010	Why?
Acetylcysteine	1	1993	135	0.010	Why?
Interview, Psychological	1	1992	105	0.010	Why?
California	1	1992	212	0.010	Why?
Marriage	1	1991	50	0.010	Why?
Psychological Tests	1	1992	136	0.010	Why?
Nutritional Physiological Phenomena	1	1991	99	0.010	Why?
Lung Diseases	1	1997	751	0.010	Why?
Practice Guidelines as Topic	1	2001	2388	0.010	Why?
Hematopoietic Stem Cell Transplantation	1	2009	7009	0.010	Why?
Self Concept	1	1992	199	0.010	Why?
Affect	1	1992	305	0.010	Why?
Methods	1	1989	221	0.010	Why?
Diet	1	1997	1476	0.010	Why?
Radiation Injuries	1	1997	1469	0.010	Why?
Analgesics	1	1991	409	0.000	Why?
Social Support	1	1991	590	0.000	Why?
Socioeconomic Factors	1	1992	1255	0.000	Why?
Child	2	1998	30466	0.000	Why?

LEE's Networks

Click the

Explore

buttons for more information and interactive visualizations!

Concepts (842)

Explore

Co-Authors (178)

Explore

Similar People (60)

Explore

Same Department

Explore